B. Puła, K. Jamroziak, T. Wróbel, K. Giannopoulos, I. Hus
{"title":"IGHV mutational status and the choice of first-line therapy for patients with chronic lymphocytic leukaemia","authors":"B. Puła, K. Jamroziak, T. Wróbel, K. Giannopoulos, I. Hus","doi":"10.5603/hcp.2022.0003","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":284891,"journal":{"name":"Hematology in Clinical Practice","volume":"51 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology in Clinical Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/hcp.2022.0003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
